This session will review little-known, emerging obesity pharmacotherapy and medical device pathways. You will have the opportunity to learn both the clinical and basic science that has led to the development of these treatment approaches, as well as the next steps and challenges for bringing the product to market. Attendees can look forward to learning about potential novel targets from both human and animal data.
You won’t want to miss this one-of-a-kind session. Free to all registered attendees of the ObesityWeek scientific sessions.
GLP-1 Receptor Agonists for the Management of Pediatric Obesity: Ready for Prime Time?
Aaron S Kelly, PhD
Endoscopic Gastric Bypass
Bryan Sandler, MD
Clinical Potential of a Novel Superabsorbent Hydrogel Technology Platform
Elaine Chiquette, PharmD
Energy-Sensing Systems as Pharmacological Targets in Obesity
Michael Zemel, PhD
Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN), 6 Month Results